Abstract
Obstructive sleep apnoea syndrome (OSAS) is a sleep-related breathing (SBD) disorder characterized by intermittent episodes of partial or complete obstruction of the upper airway, leading to cessation of breathing while asleep. OSAS elicits a series of mechanical, hemodynamic, chemical, neural, and inflammatory responses with adverse consequences on the cardiovascular system. Among these, cardiac arrhythmias are a common problem in affected patients, including both brady and tachy-arrhythmic manifestations. The strong association between OSAS and arrhythmia has prompted in last decades significant research aimed to understanding the mechanism connecting the two conditions, to define prevalence, to prospect new therapies and to explain the synergic negative effects in terms of morbidity and mortality in affected patients. In our center experience since 2009, we have focused our interest on atrial fibrillation (AF) and sleep apnea with the aim to define prevalence of SBD in a real-life population affected by AF and to assess the role of SBD on atrial remodelling, AF recurrence and therapies. Moreover, we have studied the complex relation between sleep apnoea and heart failure in patients treated with cardiac resynchronization therapy. We will report a revision of literature about sleep apnoea, AF and furthermore the main findings of our research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea. Am J Respir Crit Care Med 165(9):1217–1239
Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82–93
Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T et al (2007) Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49(5):565–571
Shepard JW, Garrison MW, Grither DA, Dolan GF (1985) Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest 88(3):335–340
Fichter J, Bauer D, Arampatzis S, Fries R, Heisel A, Sybrecht GW (2002) Sleep-related breathing disorders are associated with ventricular arrhythmias in patients with an implantable cardioverter-defibrillator. Chest 122:558–561
Leuenberger URS, Sweer L, Waravdekar N, Jacob E, Sweer L, Waravdekar N et al (1995) Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol 79(2):581–588
Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96(4):1897–1904
Xie A, Skatrud JB, Puleo DS, Morgan BJ (2001) Exposure to hypoxia produces long-lasting sympathetic activation in humans. J Appl Physiol 91(4):1555–1562
Kanagala R (2003) Obstructive Sleep apnea and the recurrence of atrial fibrillation. Circulation 107(2):2589–2594
Ng CY (2011) Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol 108(1):47–51
Pearse SG, Cowie MR, Nalliah CJ, Sanders P, Kalman JM, Chang C-C et al (2014) Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 62(4):300–305
Neilan TG, Farhad H, Dodson JA, Shah RV, Abbasi SA, Bakker JP et al (2013) Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc 2(6):e000421
Naruse Y, Tada H, Satoh M, Yanagihara M, Tsuneoka H, Hirata Y et al (2013) Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Hear Rhythm 10(3):331–337
Holmqvist F, Guan N, Zhu Z, Kowey PR, Allen LA, Fonarow GC et al (2015) Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J 169(5):647–654
Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL et al (2006) Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 173(8):910–916. Available from: https://www.ncbi.nlm.nih.gov/pubmed/16424443
Serizawa N, Yumino D, Kajimoto K, Tagawa Y, Takagi A, Shoda M et al (2008) Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter- defibrillator. Am J Cardiol 102(8):1064–1068
Voigt L, Haq SA, Mitre CA, Lombardo G, Kassotis J (2011) Effect of obstructive sleep apnea on QT dispersion: a potential mechanism of sudden cardiac death. Cardiology 118(1):68–73
Bitter T, Westerheide N, Prinz C, Hossain MS, Vogt J, Langer C et al (2011) CheyneStokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J 32(1):61–74
Ryan CM, Usui K, Floras JS, Bradley TD (2005) Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 60(9):781–785
Mehra R, Stone KL, Varosy PD, Hoffman AR, Marcus GM, Blackwell T et al (2009) Nocturnal arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study. Arch Intern Med 169(12):1147–1155
Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J et al (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy-Devel. Europace
Bitter T, Langer C, Vogt J, Lange M, Horstkotte D, Oldenburg O (2009) Sleep disordered breathing in patients with atrial fibrillation and normal systolic left ventricular function. Dtsch Aerztebl Int 106(10):164–170
Braga B, Poyares D, Cintra F, Guilleminault C, Cirenza C, Horbach S et al (2009) Sleep-disordered breathing and chronic atrial fibrillation. Sleep Med 10(2):212–216
Mazza A, Bendini MG, Cristofori M, Nardi S, Leggio M, De Cristofaro R et al (2009) Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables. Europace 11(7):902–909. Available from: http://dx.doi.org/10.1093/europace/eup107
Monahan K, Brewster J, Wang L, Parvez B, Goyal S, Roden DM et al (2012) Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol 110(3):369–372
Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Töpfer V (2007) Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 9(3):251–257
Schulz R, Blau A, Börgel J, Duchna HW, Fietze I, Koper I et al (2007) Sleep apnoea in heart failure. Eur Respir J 29(6):1201–1205. Available from: http://erj.ersjournals.com/content/29/6/1201.abstract
Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt O-A et al (2013) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 15(8):1070–1118. Available from: http://dx.doi.org/10.1093/europace/eut206
Shalaby A, Atwood CW, Selzer F, Suffoletto M, Gorcsan J, Strollo P (2011) Cardiac resynchronization therapy and obstructive sleep-related breathing disorder in patients with congestive heart failure. Pacing Clin Electrophysiol 34(5):593–603
Lüthje L, Renner B, Kessels R, Vollmann D, Raupach T, Gerritse B et al (2009) Cardiac resynchronization therapy and atrial overdrive pacing for the treatment of central sleep apnoea. Eur J Heart Fail 11(3):273–280
Simantirakis EN, Schiza SE, Siafakas NS, Vardas PE (2008) Sleep-disordered breathing in heart failure and the effect of cardiac resynchronization therapy. Europace 10(9):1029–1033
Gabor JY, Newman DA, Barnard-Roberts V, Korley V, Mangat I, Dorian P et al (2005) Improvement in Cheyne-Stokes respiration following cardiac resynchronisation therapy. Eur Respir J 26(1):95–100
Oldenburg O, Faber L, Vogt J, Dorszewski A, Szabados F, Horstkotte D et al (2007) Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing. Eur J Heart Fail 9(8):820–826
Sredniawa B, Lenarczyk R, Kowalski O, Pruszkowska-Skrzep P, Kowalczyk J, Musialik-Lydka A et al (2009) Sleep apnoea as a predictor of mid- and long-term outcome in patients undergoing cardiac resynchronization therapy. Europace 11(1):106–114
Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350(21):2140–2150. Available from: https://doi.org/10.1056/NEJMoa032423
Mabo P, Victor F, Bazin P, Ahres S, Babuty D, Da Costa A et al (2012) A randomized trial of long- term remote monitoring of pacemaker recipients (The COMPAS trial). Eur Heart J 33(9):1105–1111. Available from: http://dx.doi.org/10.1093/eurheartj/ehr419
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540–545
Rector TS, Kubo SH, Cohn JN (1993) Validity of the minnesota living with heart failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 71(12):1106–1107
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocard. J Am Soc Echocardiogr 18(12):1440–1463. Available from: https://doi.org/10.1016/j.echo.2005.10.005
Iber C, Ancoli-Israel S, Chesson AL Jr., Quan SF for the American Academy of Sleep Medicine (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, 1st edn, Westchester, IL: American Academy of Sleep Medicine
Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344(12):873–880
Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352(15):1539–1549. Available from: https://doi.org/10.1056/NEJMoa050496
Lamba J, Simpson CS, Redfearn DP, Michael KA, Fitzpatrick M, Baranchuk A (2011) Cardiac resynchronization therapy for the treatment of sleep apnoea: a meta-analysis. Europace 13(8):1174–1179. Available from: http://dx.doi.org/10.1093/europace/eur128
Anastasopoulos DL, Chalkias A, Iakovidou N, Xanthos T (2016) Effect of cardiac pacing on sleep-related breathing disorders: a systematic review. Heart Fail Rev 21(5):579–590
Stanchina ML, Ellison K, Malhotra A, Anderson M, Kirk M, Benser ME et al (2007) The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: a pilot study. Chest 132(3):433–439
Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D et al (2007) Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial. Circulation 115(25):3173–3180
Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE et al (2010) Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 121(14):1598–1605
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cipolletta, L., Urbinati, A., Matassini, M.V., Francesca, M., Gasparini, S., Capucci, A. (2020). Obstructive Sleep Apnoea Syndrome and Arrhythmia: Results of 10 Years’ Experience. In: Longhi, S., et al. The First Outstanding 50 Years of “Università Politecnica delle Marche”. Springer, Cham. https://doi.org/10.1007/978-3-030-33832-9_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-33832-9_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-33831-2
Online ISBN: 978-3-030-33832-9
eBook Packages: EducationEducation (R0)